Drug: TRUVADA Injury: Hepatocellular injury Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125546641 | TRUVADA | Hepatocellular injury | ABBVIE | 61.24 YR | F | 0 | 20160713 | FR |
125738821 | TRUVADA | Hepatocellular injury | BRISTOL MYERS SQUIBB | 61.24 YR | F | 0 | 20160720 | FR |
125993871 | TRUVADA | Hepatocellular injury | SYMPLMED PHARMACEUTICALS | 0.00 | 0 | 20160727 | FR | |
126522661 | TRUVADA | Hepatocellular injury | ABBVIE | 44.88 YR | F | 68 KG | 20160815 | FR |
126534041 | TRUVADA | Hepatocellular injury | GILEAD | 45.00 YR | F | 68 KG | 20160815 | FR |
126634771 | TRUVADA | Hepatocellular injury | JANSSEN | 44.88 YR | F | 68 KG | 20160818 | FR |
127763521 | TRUVADA | Hepatocellular injury | MERCK | 0.00 | M | 0 | 20160923 | FR |
127847571 | TRUVADA | Hepatocellular injury | GILEAD | 50.00 YR | M | 0 | 20160927 | FR |
Total Records: 8 Number of Pages: 1